BioSpace News Archive

TILT Biotherapeutics announces it has signed a second clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Rahway, NJ, USA, for a new clinical trial evaluating TILT-123, its oncolytic adenovirus armed with two human cytokines, in combination with KEYTRUDA®, MSD’s anti-PD-1 therapy.

SOMAÍ Pharmaceuticals Unipessoal LDA has officially opened its new state-of-the-art pharmaceutical EU-GMP facility in Portugal.

Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the Lytham Partners Fall 2022 Investor Conference being held September 28–29, 2022 and invites investors to participate via virtual one-on-one meetings.

Pain Specialists of America announced it is integrating the new Proclaim™ Plus spinal cord stimulation system featuring FlexBurst360™ therapy for patients receiving neuromodulation therapy for chronic pain.

TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has appointed Sara Toyloy as its fourth independent member of the Board of Directors.

Bausch + Lomb Corporation today announced that seven scientific podium and poster presentations involving its products and pipeline, as well as data from the Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) surveillance study, will be presented during the annual meeting of the American Academy of Ophthalmology (AAO), which will take place in Chicago from Sept. 30 to Oct. 3, 2022.

Pfizer Inc. and BioNTech SE announced they have completed a submission to the U.S. Food and Drug Administration requesting Emergency Use Authorization of a 10-µg booster dose of the companies’ Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for children 5 through 11 years of age.

Bio-Techne Corporation today announced that it has taken legal action in the United Kingdom to halt the infringement of its patented RNAscope® ISH technology by Molecular Instruments, Inc.

NuVasive, Inc. today announced it will continue its partnership with the Society for Minimally Invasive Spine Surgery (SMISS) as a sponsor and will attend the SMISS Annual Forum ’22 held September 29 to October 1, 2022 in Las Vegas.

Centene Corporation announced that its Nebraska subsidiary, Nebraska Total Care, has been awarded the Nebraska Department of Health and Human Services statewide Medicaid managed care contract.